Invention Grant
- Patent Title: Inhibiting fatty acid synthase (FASN)
-
Application No.: US17021759Application Date: 2020-09-15
-
Publication No.: US11299484B2Publication Date: 2022-04-12
- Inventor: Matthew W. Martin , Mary-Margaret Zablocki , Scot Mente , Christopher Dinsmore , Zhongguo Wang , Xiaozhang Zheng
- Applicant: FORMA Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: FORMA Therapeutics, Inc.
- Current Assignee: FORMA Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Barnes & Thornburg LLP
- Priority: TW108136774 20191009
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D221/20 ; C07D409/14 ; C07D413/14 ; C07D405/06

Abstract:
The present disclosure is directed to inhibitors of FASN. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of FASN. For instance, the disclosure is concerned with compounds and compositions for inhibition of FASN, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of FASN, and methods of synthesis of these compounds.
Public/Granted literature
- US20210024508A1 INHIBITING FATTY ACID SYNTHASE (FASN) Public/Granted day:2021-01-28
Information query